VYNE Therapeutics Announces Publication of Long-term Safety & Efficacy Data for ZILXI™ (minocycline) topical foam, 1.5% in the Journal of Clinical and Aesthetic Dermatology

    NEXT STORY
    Global $96.6 Billion Medical Supply Delivery Service Market to 2027 by Application, Mode Of Service (Courier, Drone), End User (Hospitals, Clinics, Diagnostic Laboratories)
    PREV STORY
    Zai Lab Appoints Alan Sandler, M.D., as President, Head of Global Development, Oncology
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Readers Follow an Emergency Room Nurse’s Experiences Saving Lives in New Novel

    author_avatar
    NASDAQ Market News

    Successful US patent strategy – Oncology Ventures Irofulven Claims Accepted

    Hoersholm; May 29th, 2017 - Medical Prognosis Institute (MPI:ST) today announced that Oncology Venture ...

    author_avatar
    NASDAQ Market News

    Abeona Therapeutics Appoints Brian Pereira and Shawn Tomasello to the Board of Directors

    author_avatar
    NASDAQ Market News